Company intelligence / Profile preview
Consun Pharmaceutical Group
Guangzhou, Guangdong Province, Chinachinaconsun.com ↗
- Ownership
- Private
- Employees
- ~3164
- Development stage
- Other
01
Overview
Consun is a leading Chinese pharmaceutical group with a strong focus on nephrology medicines and traditional Chinese medicine. It has over two decades of experience in R&D and commercialization with more than 140 marketed products covering both TCM and Western medicines. Its pipeline covers innovative drugs for kidney diseases as well as imaging agents. The company is recognized for its leadership in the domestic kidney disease market. Clinical results are positive for key products such as Niaoduqing Granules (approved), gadopentetate dimeglumine contrast agent (approved), Huangqi powder pellets (Phase II), SK‑08/SK‑07 compounds targeting CKD/Uremic pruritus at early clinical stages.
- Therapeutic areas
- Metabolic DisordersPulmonologyInfectious DiseasesEndocrinologyOtherNephrology
- Modalities
- Small moleculeHerbal medicine (Traditional Chinese Medicine)Chemical drugsContrast agent
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with Hong Kong Baptist University, Macao University of Science & Technology, Southern Medical University among others for R&D innovation consortiums.
Beyond the preview
Go deeper on Consun Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Consun Pharmaceutical Group.